Literature DB >> 13680516

Early supported discharge in stroke rehabilitation.

Robert W Teasell1, Norine C Foley, Sanjit K Bhogal, Mark R Speechley.   

Abstract

A systematic review of the randomized controlled trials published from 1970-2002 was conducted to assess the effectiveness of early supported discharge programs in the context of stroke rehabilitation. Ten studies, including 1,286 patients, were selected for detailed review. The methodological quality of the studies was assessed using the PEDro Scale. The outcome assessed included functional outcomes, cost analysis, and length of hospital stay. Although the majority of studies reported no statistically significant differences in functional outcomes between the two groups, there was a reduction in hospital stays for patients receiving home-based therapy. These results suggest that patients with milder strokes who receive home-based therapies have similar functional outcomes to patients who receive traditional inpatient rehabilitation.

Entities:  

Mesh:

Year:  2003        PMID: 13680516     DOI: 10.1310/QLFN-M4MX-XEMM-2YCQ

Source DB:  PubMed          Journal:  Top Stroke Rehabil        ISSN: 1074-9357            Impact factor:   2.119


  4 in total

Review 1.  Interventions aimed at reducing problems in adult patients discharged from hospital to home: a systematic meta-review.

Authors:  Patriek Mistiaen; Anneke L Francke; Else Poot
Journal:  BMC Health Serv Res       Date:  2007-04-04       Impact factor: 2.655

Review 2.  Defining quality outcomes for complex-care patients transitioning across the continuum using a structured panel process.

Authors:  Lianne Jeffs; Madelyn P Law; Sharon Straus; Roberta Cardoso; Renee F Lyons; Chaim Bell
Journal:  BMJ Qual Saf       Date:  2013-07-12       Impact factor: 7.035

Review 3.  A Comprehensive Neurorehabilitation Program Should be an Integral Part of a Comprehensive Stroke Center.

Authors:  Reza Bagherpour; Dennis D Dykstra; A M Barrett; Andreas R Luft; Afshin A Divani
Journal:  Front Neurol       Date:  2014-04-22       Impact factor: 4.003

4.  A retrospective cohort study of high-impact users among patients with cerebrovascular conditions.

Authors:  Ahsan Rao; Alice Jones; Alex Bottle; Ara Darzi; Paul Aylin
Journal:  BMJ Open       Date:  2017-06-24       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.